1. Home
  2. IMAB vs FONR Comparison

IMAB vs FONR Comparison

Compare IMAB & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • FONR
  • Stock Information
  • Founded
  • IMAB 2014
  • FONR 1978
  • Country
  • IMAB United States
  • FONR United States
  • Employees
  • IMAB N/A
  • FONR N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • IMAB Health Care
  • FONR Health Care
  • Exchange
  • IMAB Nasdaq
  • FONR Nasdaq
  • Market Cap
  • IMAB 73.9M
  • FONR 77.1M
  • IPO Year
  • IMAB 2020
  • FONR 1987
  • Fundamental
  • Price
  • IMAB $1.31
  • FONR $14.50
  • Analyst Decision
  • IMAB Strong Buy
  • FONR
  • Analyst Count
  • IMAB 2
  • FONR 0
  • Target Price
  • IMAB $5.50
  • FONR N/A
  • AVG Volume (30 Days)
  • IMAB 238.6K
  • FONR 42.9K
  • Earning Date
  • IMAB 05-15-2025
  • FONR 05-15-2025
  • Dividend Yield
  • IMAB N/A
  • FONR N/A
  • EPS Growth
  • IMAB N/A
  • FONR N/A
  • EPS
  • IMAB N/A
  • FONR 1.28
  • Revenue
  • IMAB N/A
  • FONR $103,018,089.00
  • Revenue This Year
  • IMAB N/A
  • FONR N/A
  • Revenue Next Year
  • IMAB N/A
  • FONR N/A
  • P/E Ratio
  • IMAB N/A
  • FONR $11.36
  • Revenue Growth
  • IMAB N/A
  • FONR 0.29
  • 52 Week Low
  • IMAB $0.60
  • FONR $12.00
  • 52 Week High
  • IMAB $2.00
  • FONR $18.68
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 76.59
  • FONR 67.86
  • Support Level
  • IMAB $0.90
  • FONR $13.33
  • Resistance Level
  • IMAB $1.47
  • FONR $14.59
  • Average True Range (ATR)
  • IMAB 0.10
  • FONR 0.57
  • MACD
  • IMAB 0.04
  • FONR 0.18
  • Stochastic Oscillator
  • IMAB 74.07
  • FONR 96.17

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Share on Social Networks: